Hepatitis B diagnosis and long-term treatment (Hepatitis B diagnosis and treatment)
Testing to find hepatitis B and long-term care to control the virus, protect the liver and lower the risk of liver damage and liver cancer.
✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review
In short
- Hepatitis B is found with blood tests; not everyone with it needs treatment, but everyone needs monitoring.
- Antiviral tablets usually control the virus rather than curing it, so treatment is often long-term or lifelong.
- Even without treatment, regular check-ups and scans matter, and some people need six-monthly liver-cancer surveillance.
- Close contacts can be protected by vaccination, and mother-to-baby spread can usually be prevented.
A plain-English summary. The detail — including risks and recovery — is below.
At a glance
A general guide. Your specialist will give you advice for your situation.
Antivirals can strongly suppress the virus and reduce liver inflammation.
Peginterferon is generally not used in advanced cirrhosis (decompensated liver disease) or some mental-health conditions.
Blood tests confirm the infection and its phase. You may feel shocked; the team should explain what it means and that it is treatable and manageable.
A clear monitoring schedule for the virus, liver, kidneys and bones.
Blood tests confirm the infection and its phase. You may feel shocked; the team should explain what it means and...
Antiviral tablets begin to suppress the virus. Blood tests check the viral load is falling and that your kidneys...
Regular check-ups (often every 6-12 months) track the virus and liver, with fibrosis checks and, for some...
Treatment usually continues long-term. Any plan to stop is made carefully by your specialist, with close...

What is hepatitis B testing and treatment?
Hepatitis B is an infection of the liver caused by the hepatitis B virus (HBV), which spreads through blood and some body fluids. Many adults clear it on their own, but some people, especially those infected at birth or in early childhood, develop a long-term (chronic) infection.
Diagnosis uses blood tests to confirm the infection, work out which phase it is in, and check whether the liver is inflamed or scarred. This tells your team whether you need treatment now or careful monitoring.
Treatment usually means antiviral tablets that suppress the virus and protect the liver. For most people these control the infection rather than curing it, and are often taken long-term or for life. Some people are offered a course of injections (peginterferon) instead.
The aims of care are to keep the virus under control, prevent or slow liver damage, lower the risk of liver cancer, and stop the virus spreading to others. This guide explains what to expect and what to ask. It is general information, not personal medical advice; your liver specialist will tailor your plan.
Types, options & approaches
There may be different ways to do this. The right approach depends on the clinical question and your circumstances.
Antiviral tablets vs peginterferon
| Feature | Tablets | Peginterferon |
|---|---|---|
| How taken | Daily tablet | Weekly injection |
| Length | Often long-term/lifelong | Around 12 months |
| Side effects | Usually few | More common (flu-like, mood, blood counts) |
| Chance of stopping | Lower | A functional cure in some people |
Which option suits you depends on the phase of infection, your liver and other health factors. Your specialist will advise.
Preparing for your treatment
- Bring details of how the infection may have been caught and any past results, if you have them.
- List all your medicines and supplements, as some interact with antivirals or affect the liver.
- Tell your clinician if you are pregnant, might become pregnant, or are breastfeeding, as this changes the plan.
- Mention any kidney or bone problems, since some antivirals are monitored for these.
- Ask whether your close contacts and household should be tested and vaccinated.
- Ask whether you need a fibrosis scan and liver-cancer surveillance, and how often.
- Avoid alcohol or keep it to a minimum, as it adds to liver strain.
What happens
Diagnosis starts with blood tests. These confirm hepatitis B (using the surface antigen, HBsAg), and further tests work out the phase of infection and how active the virus is, including the e-antigen and the viral load (HBV DNA). Tests of liver function, and a fibrosis (liver stiffness) scan, show whether the liver is inflamed or scarred.
Based on these, your specialist decides whether to treat now or to monitor. Treatment is often recommended if the viral load is high, liver tests are persistently raised, there is cirrhosis, or during pregnancy when virus levels are high.
If you start antiviral tablets, you take one a day and have regular blood tests to check they are working and to watch your kidneys and bones. If monitoring rather than treating, you have regular check-ups, fibrosis checks and, for some people, six-monthly liver-cancer surveillance scans. Vaccination of close contacts is arranged.
Is this treatment right for me?
A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.
May not be suitable if…
- Peginterferon is generally not used in advanced cirrhosis (decompensated liver disease) or some mental-health conditions.
- Antiviral tablets should not be started or stopped casually; this is a specialist decision because of flare risk.
- Not everyone needs treatment immediately; treating someone in a low-activity phase may add side effects without clear benefit.
- Over-the-counter 'liver support' products do not treat hepatitis B and may interfere with care.
Delay or rearrange if…
- You are acutely unwell or jaundiced and need urgent assessment rather than routine clinic care.
- You are pregnant or planning pregnancy, so the plan can be tailored to protect the baby.
- Key tests (viral load, e-antigen, fibrosis assessment) have not yet been done to guide treatment.
- You are about to start, or are on, strong immune-suppressing treatment that changes the timing of antivirals.
Alternatives to discuss
- Careful monitoring without antivirals in certain phases of infection.
- Peginterferon as an alternative to long-term tablets in selected people.
- NHS specialist care as an alternative to private pathways.
- Focusing on prevention (vaccinating contacts) and general liver health where treatment is not yet needed.
Before you decide
Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.
What matters most to me?
Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.
What are all my options?
Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.
What would make me pause?
Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.
What happens if I do nothing today?
For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.
Benefits
- Antivirals can strongly suppress the virus and reduce liver inflammation.
- Controlling the virus lowers the risk of cirrhosis and liver cancer over time.
- Treatment in pregnancy can greatly reduce the chance of passing the virus to the baby.
- Regular surveillance can find liver cancer early, when treatment can often cure it.
- Vaccinating close contacts protects the people around you.
Risks & complications
- Needing long-term, sometimes lifelong, tablets and regular blood tests
- Mild side effects from antivirals in some people
- Flu-like symptoms, low mood and low blood counts with peginterferon
- The reassurance of normal results not being permanent, so monitoring continues
- Kidney effects or reduced bone density with long-term tenofovir, which is monitored
- A flare of liver inflammation, especially if treatment is stopped without advice
- Resistance to older antivirals (less of an issue with tenofovir and entecavir)
- Severe interferon side effects affecting mood, thyroid or other organs
- Serious liver flare or decompensation, particularly with advanced disease
- Reactivation of the virus during strong immune-suppressing treatment for other illnesses
The most important point is that chronic hepatitis B usually cannot be fully cured, so stopping tablets without specialist advice can trigger a dangerous flare. Ask how long you will need treatment, how your kidneys and bones will be monitored, and whether you need liver-cancer surveillance.
Published figures to discuss
How hepatitis B behaves, and how well treatment works, varies with the phase of infection, the viral load, the degree of liver scarring and other factors. The pointers below are broad and source-based, not predictions for any individual.
| Figure | Reported range | How to interpret it | Source / confidence |
|---|---|---|---|
| Adults who clear acute hepatitis B without treatment | Around 9 in 10 (about 90-95%) | Most adults clear the virus; infection in babies and young children far more often becomes chronic. | NICE CG165 - Hepatitis B (chronic): diagnosis and managementnice.org.ukPublished figure |
| Resistance with modern first-line antivirals | Very low with tenofovir or entecavir | Resistance was a bigger problem with older drugs; modern agents have a high barrier to resistance. | Guide sourcesClinical context |
| Cirrhosis or liver cancer in chronic hepatitis B | Risk varies by viral load, age, sex, family history, fibrosis stage and treatment | Some people need antiviral treatment and ultrasound surveillance even when they feel well. | NICE CG165 - Hepatitis B (chronic): diagnosis and managementnice.org.ukSource-linked context |
| Hepatitis B reactivation during immunosuppression | Clinically important and preventable | HBV testing before chemotherapy, biologics or high-dose steroids allows prophylaxis when needed. | Guide sourcesClinical context |
These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.
What happens afterwards
There is no physical recovery from a blood test or daily tablet. "Afterwards" is really about long-term monitoring and what your results mean for your liver and the people around you.
- Most people feel no different on antiviral tablets
- Viral load usually falls over the first months of treatment
- Liver blood tests often improve but are still monitored
- Needing ongoing appointments rather than a one-off 'cure'
Aftercare
- Take antiviral tablets every day as prescribed; do not stop without specialist advice.
- Attend all monitoring appointments, blood tests and scans, even when you feel well.
- Make sure close contacts and household members are tested and vaccinated if needed.
- Keep alcohol low and look after general liver health.
- Tell any clinician treating you that you have hepatitis B, especially before strong immune-suppressing drugs or chemotherapy.
- If pregnant or planning pregnancy, discuss steps to protect the baby.
- Know who to contact if you develop jaundice or feel unwell.
- Antiviral prescription and repeat supply arranged
- Monitoring schedule written down (viral load, liver and kidney tests)
- Liver-cancer surveillance arranged if recommended
- Close contacts offered testing and vaccination
- Plan in place if pregnant or planning pregnancy
- Out-of-hours contact saved in case of warning signs
⚠ Get urgent help if…
- Yellowing of the skin or eyes (jaundice) that is new or worsening
- Dark urine, pale stools, or severe tummy pain
- Marked tiredness, confusion or drowsiness
- Vomiting blood or passing black, tarry stools - call 999
- Swelling of the tummy or legs
- Severe low mood or thoughts of self-harm while on interferon - seek urgent help
Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.
General guidance — it doesn't replace the specific advice your specialist gives you.
Results & realistic expectations
A good result on treatment usually means the virus is strongly suppressed (a low or undetectable viral load) and liver tests are stable, lowering the long-term risk of cirrhosis and liver cancer. With peginterferon, a smaller number of people reach a "functional cure" and may be able to stop treatment.
What treatment usually cannot do is completely clear the virus, because it can hide in liver cells. That is why monitoring, and for some people surveillance for liver cancer, continues even when results look good.
With effective, sustained antiviral treatment many people with chronic hepatitis B live a normal lifespan with a well-controlled liver. The benefit lasts as long as the virus stays suppressed, which is why treatment is often long-term. Results are reviewed regularly, and the plan may change over the years.
Related tests, treatments or support
Hepatitis B care is often coordinated with vaccination against hepatitis A, checks for hepatitis C and HIV, and management of other liver risks such as alcohol or fatty liver. If you have cirrhosis, surveillance and management of complications are combined with antiviral treatment.
Follow-up & long-term care
Follow-up is long-term. People on treatment have regular blood tests to confirm the virus stays suppressed and to monitor kidneys and bones. Those not on treatment are reviewed regularly, often every 6-12 months, with fibrosis checks and, for some, six-monthly liver-cancer surveillance.
- Daily antiviral tablets, often long-term or lifelong
- Regular viral load, liver and (for tenofovir) kidney and bone monitoring
- Fibrosis assessment at set intervals
- Six-monthly liver-cancer surveillance for those at higher risk
- Keeping close contacts vaccinated and protected
- Review before any strong immune-suppressing treatment for other conditions
Repeat, follow-on and what comes next
- Treatment decisions are reviewed over time as the phase of infection and liver tests change.
- If one antiviral is not tolerated or is unsuitable, another can usually be used.
- Some people who are monitored will later need treatment, and a few on peginterferon may stop after a functional cure.
Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.
What good aftercare looks like
- A clear monitoring schedule for the virus, liver, kidneys and bones.
- Liver-cancer surveillance arranged and explained for those at higher risk.
- A named contact and clear advice on when to seek urgent help.
- Testing and vaccination organised for partners, household and family.
- Coordination with maternity care in pregnancy to protect the baby.
What affects the cost
Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:
- Initial blood tests, fibrosis scan and specialist consultation
- Whether you need treatment or monitoring, and how often you are reviewed
- The medicine used (long-term antiviral tablets versus a course of injections)
- Regular monitoring of viral load, liver, kidneys and bones
- Liver-cancer surveillance scans if recommended
- Testing and vaccinating close contacts
- The specialist's consultation and follow-up fees
- Costs of diagnostic and monitoring blood tests, and how often
- The cost of antiviral medicines and who prescribes repeats
- Whether fibrosis scans and liver-cancer surveillance are included
- Whether testing and vaccinating contacts is covered
- What happens, and who pays, if a liver flare or complication occurs
On the NHS? Hepatitis B testing, treatment and monitoring are available on the NHS; private care is mainly used for speed, choice of clinician or a second opinion.
You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.
Consent traps and marketing red flags
These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.
Consent traps
- Not being warned that stopping antivirals without advice can cause a dangerous liver flare.
- Being told the infection is 'cured' rather than controlled.
- No arrangement for liver-cancer surveillance in someone at higher risk.
- Close contacts not offered testing and vaccination.
- No plan for kidney and bone monitoring on long-term tenofovir.
Marketing red flags
- Claims that a supplement, herbal product or infusion can cure hepatitis B.
- Offering antivirals without proper monitoring of the virus, liver and kidneys.
- Not mentioning liver-cancer surveillance where it is recommended.
- Promising a quick cure with a short course of treatment for chronic infection.
Choosing a specialist safely
- Check the specialist is on the GMC Specialist Register for this area.
- Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
- You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
- Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
- You're entitled to your total cost in writing — including any follow-up — before you decide.
Questions to ask your medical professional
Take this to your consultation. A good specialist will welcome every one of these.
- What phase is my hepatitis B in, and do I need treatment now or monitoring?
- If I start antivirals, how long will I take them and how will my kidneys and bones be monitored?
- Do I need liver-cancer surveillance, and how often?
- Should my partner, household and family be tested and vaccinated?
- If I am pregnant or planning a baby, how will you protect my child?
- What would happen, and what are the warning signs, if treatment were ever stopped?
- Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
- Will you be the specialist who carries out my treatment, and who looks after me afterwards?
- What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
- What does a realistic result look like — and what can this treatment not achieve?
- What are my options, including waiting, doing nothing for now, or choosing a different approach?
- Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
- What is the total cost in writing, including any follow-ups, and how much time do I have to decide?
Frequently asked questions
Can hepatitis B be cured?
Will I have to take tablets for life?
Do I need treatment if I feel well?
Can I pass it to my family?
Is treatment available on the NHS?
Why do I need scans if my liver tests are normal?
Find a verified specialist for hepatitis b diagnosis and long-term treatment
Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.
No verified consultants list this procedure yet — browse the full directory.
How we made this page
Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →
Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.
Sources & standards: British Liver Trust - Hepatitis B British Liver Trust - Treatment for hepatitis B NICE CG165 - Hepatitis B (chronic): diagnosis and management NICE - Hepatitis B (chronic): drug treatment (information for the public) NHS - Hepatitis B
Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.
Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.
Related guides: Hepatitis C diagnosis and treatment · Alcohol-related liver disease care · Autoimmune hepatitis care · Cirrhosis management and monitoring · Haemochromatosis (iron overload) management